Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Healthcare Company (ACHC) Return on Sales (2016 - 2025)

Historic Return on Sales for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to 0.04%.

  • Acadia Healthcare Company's Return on Sales fell 400.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.08% for FY2024, which is 1200.0% up from last year.
  • Acadia Healthcare Company's Return on Sales amounted to 0.04% in Q3 2025, which was down 400.0% from 0.04% recorded in Q2 2025.
  • In the past 5 years, Acadia Healthcare Company's Return on Sales registered a high of 0.13% during Q2 2022, and its lowest value of 0.38% during Q2 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.04% (2025), whereas its average is 0.0%.
  • Over the last 5 years, Acadia Healthcare Company's Return on Sales had its largest YoY gain of 15300bps in 2021, and its largest YoY loss of -4100bps in 2021.
  • Acadia Healthcare Company's Return on Sales (Quarter) stood at 0.01% in 2021, then skyrocketed by 1812bps to 0.09% in 2022, then plummeted by -149bps to 0.05% in 2023, then surged by 194bps to 0.04% in 2024, then grew by 4bps to 0.04% in 2025.
  • Its last three reported values are 0.04% in Q3 2025, 0.04% for Q2 2025, and 0.01% during Q1 2025.